Omnicell, Inc.
Index- P/E80.61 EPS (ttm)1.49 Insider Own1.20% Shs Outstand44.25M Perf Week7.75%
Market Cap5.13B Forward P/E26.80 EPS next Y4.48 Insider Trans-1.21% Shs Float43.57M Perf Month9.47%
Income71.90M PEG5.37 EPS next Q0.85 Inst Own- Short Float7.69% Perf Quarter-7.87%
Sales1.20B P/S4.28 EPS this Y120.60% Inst Trans1.14% Short Ratio8.12 Perf Half Y-32.65%
Book/sh24.29 P/B4.94 EPS next Y14.95% ROA3.50% Target Price160.25 Perf Year-20.23%
Cash/sh6.46 P/C18.58 EPS next 5Y15.00% ROE6.60% 52W Range104.32 - 187.29 Perf YTD-33.43%
Dividend- P/FCF41.72 EPS past 5Y43.70% ROI6.20% 52W High-35.87% Beta1.10
Dividend %- Quick Ratio0.70 Sales past 5Y10.20% Gross Margin48.60% 52W Low15.14% ATR4.73
Employees3800 Current Ratio0.80 Sales Q/Q26.60% Oper. Margin6.20% RSI (14)57.76 Volatility4.63% 4.05%
OptionableYes Debt/Eq0.53 EPS Q/Q-43.70% Profit Margin6.00% Rel Volume0.87 Prev Close124.09
ShortableYes LT Debt/Eq0.00 EarningsApr 28 AMC Payout0.00% Avg Volume412.96K Price120.11
Recom2.10 SMA205.91% SMA506.49% SMA200-17.56% Volume360,555 Change-3.21%
Dec-06-21Resumed Wells Fargo Overweight $203
Jun-09-21Initiated JP Morgan Neutral $146
May-24-21Initiated BTIG Research Buy $165
Feb-02-21Upgrade Piper Sandler Neutral → Overweight $86 → $147
Dec-08-20Initiated Berenberg Buy $145
Dec-03-20Downgrade Cantor Fitzgerald Overweight → Neutral $95
Jul-07-20Initiated Stephens Overweight $90
Feb-07-20Reiterated Dougherty & Company Buy $92 → $100
Nov-21-19Reiterated Dougherty & Company Buy $90 → $92
Jul-26-19Upgrade Craig Hallum Hold → Buy $85
Mar-07-19Reiterated Dougherty & Company Buy $78 → $90
Jun-29-18Resumed The Benchmark Company Buy $63
Sep-05-17Reiterated The Benchmark Company Buy $55 → $67
Jul-28-17Reiterated Dougherty & Company Buy $45 → $49
Apr-21-17Downgrade Piper Jaffray Overweight → Neutral
Jan-19-17Initiated Dougherty & Company Buy $44
Dec-06-16Reiterated The Benchmark Company Buy $39 → $55
Jul-07-16Reiterated FBR Capital Outperform $35 → $40
Mar-21-16Reiterated Topeka Capital Markets Buy $38 → $37
Jan-07-16Initiated The Benchmark Company Buy $33
Jun-28-22 06:28PM  
Jun-27-22 11:34AM  
Jun-24-22 12:31PM  
Jun-23-22 12:16PM  
Jun-22-22 12:24PM  
Jun-20-22 12:11PM  
Jun-17-22 11:33AM  
Jun-16-22 10:52AM  
Jun-15-22 10:46AM  
Jun-14-22 07:59AM  
Jun-08-22 11:40AM  
Jun-02-22 01:03PM  
May-25-22 09:00AM  
May-23-22 11:25AM  
May-20-22 09:03AM  
May-19-22 12:34PM  
May-18-22 11:27AM  
May-17-22 10:22AM  
May-16-22 10:48AM  
May-13-22 10:12AM  
May-11-22 11:00AM  
May-10-22 11:12AM  
May-09-22 11:15AM  
May-06-22 12:17PM  
May-05-22 11:40AM  
May-04-22 10:59AM  
May-03-22 09:41AM  
May-02-22 06:20AM  
Apr-29-22 06:20AM  
Apr-28-22 05:25PM  
Apr-27-22 08:00AM  
Apr-19-22 11:40AM  
Apr-05-22 04:01PM  
Apr-01-22 04:11PM  
Mar-30-22 11:22AM  
Mar-29-22 08:00AM  
Mar-17-22 03:52AM  
Mar-16-22 11:30AM  
Mar-02-22 06:21AM  
Mar-01-22 04:01PM  
Feb-28-22 11:40AM  
Feb-23-22 06:20AM  
Feb-15-22 09:48AM  
Feb-14-22 05:15PM  
Feb-10-22 11:40AM  
Feb-07-22 03:00PM  
Feb-04-22 08:25AM  
Feb-03-22 01:38PM  
Feb-02-22 05:38PM  
Jan-26-22 10:36AM  
Jan-19-22 01:38PM  
Jan-12-22 07:09PM  
Jan-07-22 09:04AM  
Jan-06-22 10:21AM  
Jan-05-22 04:01PM  
Jan-04-22 08:01AM  
Dec-31-21 09:40AM  
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seidelmann Scott PeterEVP, CHIEF COMMERCIAL OFFICERJun 16Sale110.153,765414,73240,789Jun 17 05:11 PM
PARRISH MARK WDirectorApr 06Option Exercise14.872,00029,74046,558Apr 08 04:07 PM
PARRISH MARK WDirectorMar 25Option Exercise14.872,00029,74044,558Mar 28 04:15 PM
Seidelmann Scott PeterEVP, Chief Commercial OfficerMar 16Sale133.112,525336,10348,380Mar 16 04:29 PM
PARRISH MARK WDirectorMar 10Option Exercise14.872,00029,74042,558Mar 11 05:24 PM
PARRISH MARK WDirectorFeb 18Option Exercise14.873,00044,61040,558Feb 22 07:04 PM
PARRISH MARK WDirectorFeb 15Option Exercise0.003,000037,558Feb 15 07:06 PM
Moore Vance B.DirectorFeb 10Option Exercise0.0025,951067,218Feb 10 05:44 PM
JOHNSTON DAN SEVP & Chief Legal & AdminDec 16Sale176.881,063188,01925,831Dec 16 05:57 PM
Seidelmann Scott PeterEVP, Chief Commercial OfficerDec 16Sale176.903,628641,77833,632Dec 16 05:57 PM
SPEARS JOSEPH BRIANChief Accounting Officer & VPDec 08Sale180.766,9761,260,9539,399Dec 08 06:34 PM
Kuipers Peter J.Executive V P& CFODec 07Option Exercise0.005,640059,592Dec 08 06:35 PM
SPEARS JOSEPH BRIANChief Accounting Officer & VPDec 07Sale181.141,179213,56416,375Dec 08 06:34 PM
Kuipers Peter J.Executive V P& CFODec 07Sale181.158,5171,542,86051,075Dec 08 06:35 PM
SPEARS JOSEPH BRIANChief Accounting Officer & VPNov 16Option Exercise0.0038,585056,139Nov 17 11:50 AM
SPEARS JOSEPH BRIANChief Accounting Officer & VPNov 16Sale180.3638,5856,959,33617,554Nov 17 11:50 AM
JOHNSTON DAN SEVP & Chief Legal & AdminNov 02Option Exercise0.005,358034,334Nov 02 07:08 PM
JOHNSTON DAN SEVP & Chief Legal & AdminNov 02Sale180.005,358964,44028,976Nov 02 07:08 PM
JOHNSTON DAN SEVP & Chief Legal & AdminOct 26Option Exercise0.0010,451039,427Oct 27 12:54 PM
JOHNSTON DAN SEVP & Chief Legal & AdminOct 26Sale170.0010,4511,776,67028,976Oct 27 12:54 PM
Judson James TDirectorAug 23Sale153.004,984762,55118,336Aug 23 07:06 PM
Seim Robin GeneDirectorAug 09Sale151.606,6861,013,58630,049Aug 10 05:33 PM
Kuipers Peter J.Executive V P& CFOAug 06Option Exercise0.005,640065,452Aug 06 07:49 PM
JOHNSTON DAN SEVP & Chief Legal & AdminAug 06Option Exercise0.005,094033,823Aug 06 07:48 PM
Kuipers Peter J.Executive V P& CFOAug 06Sale157.8811,5001,815,63653,130Aug 06 07:49 PM
JOHNSTON DAN SEVP & Chief Legal & AdminAug 06Sale160.005,094815,04028,729Aug 06 07:48 PM
Seidelmann Scott PeterEVP, Chief Commercial OfficerAug 05Option Exercise0.0038,250082,267Aug 06 05:48 PM
Seidelmann Scott PeterEVP, Chief Commercial OfficerAug 05Sale153.0541,8786,409,29140,389Aug 06 05:48 PM
Kuipers Peter J.Executive V P& CFOAug 02Option Exercise0.0015,587081,909Aug 03 04:21 PM
Kuipers Peter J.Executive V P& CFOAug 02Sale146.1122,0973,228,61959,812Aug 03 04:21 PM
JOHNSTON DAN SEVP & Chief Legal & AdminJul 20Option Exercise0.0024,489059,965Jul 21 04:29 PM
JOHNSTON DAN SEVP & Chief Legal & AdminJul 20Sale151.3531,2364,727,70728,729Jul 21 04:29 PM